Zhan Jun, Wang Dingding, Luo Chuanxiang, Bi Haiyan
Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, People's Republic of China.
Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, People's Republic of China.
Ther Clin Risk Manag. 2024 Sep 7;20:597-610. doi: 10.2147/TCRM.S478593. eCollection 2024.
Umbilical vascular thromboembolism is a rare condition that can lead to serious consequences such as fetal hypoxia, fetal growth restriction, and even stillbirth. However, there is currently a lack of research on the pathology, pathogenesis, clinical management, and prognosis of this condition. Therefore, the purpose of this article is to analyze this condition's high-risk factors, clinical characteristics, pregnancy management, and discuss its corresponding pregnancy outcomes. Databases such as PubMed are searched using the relevant keywords of umbilical vascular thromboembolism in worldwide. And related information is analyzed such as maternal risk factors, fetal risk factors, umbilical cord and placental risk factors, and pregnancy outcomes. The literature search yields 113 articles, 64 of which meet the inclusion criteria for umbilical vascular thromboembolism. There are 4 retrospective cohort studies and 8 case series, the rest are all case reports. A total of 262 cases of umbilical vascular thromboembolism are found. The most common maternal complications and fetal related risk factors are diabetes (25 cases, 9.5%) and stillbirths (106 cases, 40.5%), respectively. Among these 262 cases, 98 (37.4%) cases are found by prenatal ultrasound to have umbilical vascular thromboembolism and the fetus is in a viable state with complete clinical information. In addition, considering the effectiveness and safety of low molecular weight heparin in thromboembolic conditions, twenty-four patients of umbilical artery thromboembolism attempted to use low molecular weight heparin during observation. Maternal diabetes was the highest risk factor for this condition. When umbilical artery thromboembolism occurs, the incidence of stillbirth increases. Premature patients with this condition can continue their pregnancy under close external monitoring. However, due to the small sample size, further research is needed.
脐血管血栓栓塞是一种罕见病症,可导致严重后果,如胎儿缺氧、胎儿生长受限,甚至死产。然而,目前对于该病症的病理学、发病机制、临床管理及预后缺乏研究。因此,本文旨在分析该病症的高危因素、临床特征、妊娠管理,并探讨其相应的妊娠结局。使用脐血管血栓栓塞的相关关键词在全球范围内检索PubMed等数据库,并分析诸如母体危险因素、胎儿危险因素、脐带和胎盘危险因素以及妊娠结局等相关信息。文献检索共得到113篇文章,其中64篇符合脐血管血栓栓塞的纳入标准。有4项回顾性队列研究和8个病例系列,其余均为病例报告。共发现262例脐血管血栓栓塞病例。最常见的母体并发症和与胎儿相关的危险因素分别为糖尿病(25例,9.5%)和死产(106例,40.5%)。在这262例病例中,98例(37.4%)通过产前超声发现有脐血管血栓栓塞且胎儿处于存活状态,临床信息完整。此外,考虑到低分子量肝素在血栓栓塞病症中的有效性和安全性,24例脐动脉血栓栓塞患者在观察期间尝试使用低分子量肝素。母体糖尿病是该病症的最高危险因素。当发生脐动脉血栓栓塞时,死产发生率增加。患有该病症的早产患者可在密切的外部监测下继续妊娠。然而,由于样本量小,还需要进一步研究。